Nurix Therapeutics (NRIX) Cash from Operations Growth (3y) (2022 - 2026)
Nurix Therapeutics (NRIX) Cash from Operations Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
37.40% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
16.64% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nurix Therapeutics |
1.93 Bn |
1.39 Bn |
- |
-14.07% |
| Date | Value |
|---|
| Feb 28, 2026 |
-14.07% |
| Nov 30, 2025 |
-21.35% |
| Aug 31, 2025 |
-7.41% |
| May 31, 2025 |
-24.27% |
| Feb 28, 2025 |
-12.74% |
| Nov 30, 2024 |
-16.40% |
| Aug 31, 2024 |
-12.06% |
| May 31, 2024 |
-7.98% |
| Feb 29, 2024 |
-93.18% |
| Nov 30, 2023 |
48.93% |
| Aug 31, 2023 |
-88.50% |
| May 31, 2023 |
-8.58% |
| Feb 28, 2023 |
-47.09% |
| Nov 30, 2022 |
-43.86% |
